To deeply investigate whether CD1d was associated with changes in the fecal microbiota in NAFLD, we performed Illumina MiSeq high-throughput sequencing to explore intestinal flora diversity in fecal samples. The gene discussed is CD1D; the disease is metabolic dysfunction-associated steatotic liver disease.